BAT Releases 2024 First Half Trading Update for June 4th

Jun.05.2024
BAT Releases 2024 First Half Trading Update for June 4th
BAT releases positive trading update for first half of 2024, anticipates accelerated growth in second half. CEO confident in continued performance.

On June 4th, British American Tobacco (BAT) released a trading update for the first half of 2024. The company revealed that its operational performance in the first half of the year met expectations and it expects growth to accelerate in the second half. This is attributed to the launch of innovative products in new business areas, as well as benefits from investment in commercial actions in the US and inventory flow from related wholesale distributors.


The company's CEO Tadeu Marroco stated:


The company's performance to date has been in line with our expectations. We plan to achieve single-digit revenue and operating profit growth on a year-over-year basis by 2024, followed by revenue growth of 3-5% and mid-single-digit adjusted operating profit growth by 2026 (calculated on an organic and fixed exchange rate basis).


The company stated that its e-cigarette brand Vuse maintains a 41.1% global market share in the e-cigarette market, still holding a leading position. In the US market, it occupies a 51.5% market share. However, due to the illegal growth of disposable e-cigarettes, its performance will be affected. The company emphasized that Vuse will introduce a new disposable e-cigarette Vuse Go 2.0 in 2024, expecting sales and revenue to accelerate in the second half of the year.


Furthermore, since January, sales of the heated tobacco category Glo have gradually recovered their market share in key markets, mainly due to positive consumer response to the new product Glo Hyper Pro and improved consumables. Its market share has remained stable in Japan and Italy, while showing strong performance in the AME market (Asia, Middle East, Africa), Poland, and the Czech Republic. In addition, the non-tobacco consumables line VEO has been launched in 17 markets and plans to further expand during the year. The company expects the momentum of Glo's market share to continue and drive revenue improvement in the second half of the year.


Velo's overall market share in key markets has risen to 10.3%, while the market share for modern oral products remains steady at 27.0%. The AME market (Asia, Middle East, Africa) is leading, including mature markets such as Sweden, Denmark, and Norway, as well as emerging markets like the UK and Poland. The re-launched Velo brand in the US has shown promising initial results, with market share in the test market of New York increasing to 13.5%. BAT expects Velo to continue strong financial performance in the first half and full year of 2024.


As previously emphasized, we expect our performance to improve in the second half of the year, primarily due to changes in wholesalers' inventory, our ongoing business investments in the US market, and the phased launch of new products. However, due to macroeconomic pressures and a lack of effective enforcement against the illegal e-cigarette market, revenue and adjusted operating profit in the first half of the year are expected to decline by single digits. Our focus on quality growth is beginning to drive higher returns in all three new categories, especially in heated tobacco and modern oral products. Therefore, we anticipate profitability in the new categories to further improve in the first half and full year.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

 NYT: Reynolds American Donated $5 Million Before FDA Vape Policy Shift
NYT: Reynolds American Donated $5 Million Before FDA Vape Policy Shift
According to The New York Times, Reynolds American donated $5 million to a Trump-backed super PAC shortly before the FDA introduced a new policy that could benefit major tobacco companies seeking to sell flavored vaping products.
News
May.21
France Bans Zyn and Other Nicotine Pouches, Violators Face Jail and Fines
France Bans Zyn and Other Nicotine Pouches, Violators Face Jail and Fines
France has officially banned nicotine pouches and other oral nicotine products, including Zyn. The new regulation classifies such products as “toxic substances” and imposes criminal penalties on their use, possession, purchase, and sale. Violators may face up to five years in prison and fines of up to €400,000 (approximately $436,600).
Regulations
May.25
 RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
Richard Danker, a senior public affairs official in Health Secretary Robert F. Kennedy Jr.’s team, resigned from his role at HHS over the FDA’s recent authorization of fruit-flavored vaping products. In a resignation letter addressed to President Donald Trump, Danker argued that the products could expose minors to nicotine addiction, lung damage, and increased cancer risks, while also conflicting with recent HHS guidance on youth risks associated with flavored nicotine products.
News
May.15
Data|China’s January-May Vape Exports: U.S. Shipments Fall 13.8% as Japan Posts Fastest Growth
Data|China’s January-May Vape Exports: U.S. Shipments Fall 13.8% as Japan Posts Fastest Growth
According to China Customs export data analyzed by 2Firsts, the United States remained China’s largest destination for vape-related exports during January-May 2026 despite a 13.82% year-on-year decline in export value. Meanwhile, exports to Japan, Russia, Indonesia and the United Arab Emirates recorded strong growth, highlighting continued diversification across China’s export markets.
Special Report
Jun.29
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.
May.12
Trump Reportedly Signs Off on Plan to Fire FDA Commissioner Marty Makary
Trump Reportedly Signs Off on Plan to Fire FDA Commissioner Marty Makary
According to The Wall Street Journal, people familiar with the matter said President Trump has signed off on a plan to fire FDA Commissioner Marty Makary, though the plan is not yet final and could change. The report said Makary’s tenure has included clashes over vaping, abortion and drug policy, and that some senior administration officials view him as struggling to manage the agency.
May.09 by 2FIRSTS.ai